With the rapid turnaround time of Antech's new test, veterinarians can now identify the appropriate treatment for both IBD and non-IBD dogs, using data to explain why a treatment path or additional diagnostic procedures are needed. While common clinical signs of IBD, they are also associated with a wide range of gastrointestinal disorders.
Knowing if a dog's symptoms are consistent with IBD, and the potential underlying cause, has allowed us to get the right treatment to a dog faster, making the new test an incredibly welcome addition to our hospitals' strong arsenal of innovative diagnostics."Ĭhronic vomiting and diarrhea are two of the most common reasons dog owners visit the veterinarian. With the Canine CE-IBD assay, we can now help and help quickly.
"A dog with chronic vomiting and diarrhea can be quite ill and may have underlying nutritional deficiencies additionally, these symptoms can be quality of life limiting for both the dog and the pet parents. "One of the most frustrating experiences for a veterinarian is being unable to relieve symptoms which are chronic, recurrent and cause distress to the animal," said Kelly Cairns DVM, MS, DACVIM, director of specialty and emergency medicine and national director of internal medicine at Pathway Vet Alliance. We can inspire confidence in a worried pet owner and gain ongoing commitment to our care recommendations, ultimately supporting a dog's rapid return to health." "The opportunity to rule in or rule out IBD early, identify possible causes and use evidence-based medicine to help pet owners understand care recommendations-all quickly and cost-effectively-allow us to treat a dog who is suffering faster. "Diagnosing IBD and identifying the underlying cause used to be a lengthy, expensive process that was frustrating for both clinicians and pet owners," said Jennifer Ogeer, BSc., DVM, MSc., MBA, MA, VP Medical Affairs & Commercial Marketing.
#ANTECH DIAGNOSTICS LOGO SERIAL#
Monitoring serial biomarker levels over time may help veterinarians evaluate treatment effectiveness and make appropriate treatment adjustments. Veterinarians can use biomarker levels to recommend and explain additional diagnostic recommendations (e.g., diagnostic imaging, GI endoscopy for biopsies) to pet owners to further define their pet's disease and develop effective treatment plans. Biomarker levels to substantiate and aid with diagnosis and support treatment monitoringīiomarker measurements for gliadin sensitivity (similar to gluten sensitivity), bacterial proliferation ( Escherichia coli) and intestinal inflammation allow veterinarians to identify possible causes of a dog's gastrointestinal clinical signs, which could be chronic enteropathy or food sensitivity. The first diagnostic usage can be when a dog has been experiencing symptoms for about 3-7 days but ideally when symptoms persist for a minimum of 3 weeks.Ģ. Two results: "consistent with CE/IBD" or "not consistent with CE/IBD" allow veterinarians to rule in or rule out IBD early and with confidence. Antech's cost-effective improvement to this standard of care offers two levels of clinical insight: However, traditional methods to diagnose IBD are invasive, time-consuming and expensive, leading to treatment delays. Rapid access to proper treatment is critical. Loss of appetite, weight loss and even anorexia can occur. IBD causes a dog's intestines to become inflamed, interfering with its ability to digest and absorb nutrients. A first in veterinary medicine, the new Canine CE-IBD assay facilitates a higher level of care for dogs with GI symptoms, supporting a more rapid return to health. The Canine CE-IBD assay is a non-invasive test that incorporates data from three biomarkers, which provide objective measurements of disease, to allow rapid, accurate diagnosis of "consistent with CE/IBD" or "not consistent with CE/IBD." The use of biomarkers, described in a study published in an ApJournal of Veterinary Internal Medicine (JVIM) article, helps veterinarians ascertain whether inflammatory disease is present, reinforce the need for further diagnostic procedures, develop more personalized treatment plans, and even monitor a dog's response to therapy. FOUNTAIN VALLEY, Calif., J/PRNewswire/ - Antech Diagnostics, part of Mars Veterinary Health, announced today that its novel blood test for canine inflammatory bowel disease (IBD), also called canine chronic enteropathy (CCE), is now available.
0 kommentar(er)
